This seminar explored why it is important to study sex and gender differences in people who inject drugs, with reference to examples relevant to hepatitis C risk and the cascade of care. It included an overview of why we study sex and gender in health research, an overview of some of the key sex and gender differences identified among people who inject drugs, and discussed findings from recent work on sex and gender differences in hepatitis C risk and the cascade of care among people who inject drugs.
It was presented by Sarah Larney, an Associate Professor at the Université de Montréal and principal researcher at the Centre de recherche du centre hospitalier de l’Université de Montréal. Her research focuses on the health and wellbeing of people who inject drugs.
